Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of PENG Block and Intrathecal Morphine in Terms of Early Postoperative Quality of Recovery and Analgesic Efficacy in Patients Undergoing Elective Total Hip Arthroplasty: A Prospective Randomized Controlled Trial

NCT07803133 is registered in ClinicalTrials.gov with Erzincan Binali Yildirim Universitesi as lead sponsor.

NCT NCT07803133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07803133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of PENG Block and Intrathecal Morphine in Terms of Early Postoperative Quality of Recovery and Analgesic Efficacy in Patients Undergoing Elective Total Hip Arthroplasty: A Prospective Randomized Controlled Trial
Lead sponsor
Erzincan Binali Yildirim Universitesi
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 1, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain